-
1
-
-
79952284127
-
Hallmarks of cancer: the next generation
-
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74; http://dx.doi.org/10.1016/j.cell.2011.02.013
-
(2011)
Cell
, vol.144
, pp. 646-674
-
-
Hanahan, D.1
Weinberg, R.A.2
-
3
-
-
45749134564
-
The anticancer immune response: indispensable for therapeutic success?
-
Zitvogel L, Apetoh L, Ghiringhelli F, André F, Tesniere A, Kroemer G. The anticancer immune response: indispensable for therapeutic success? J Clin Invest 2008; 118:1991-2001; http://dx.doi.org/10. 1172/JCI35180
-
(2008)
J Clin Invest
, vol.118
, pp. 1991-2001
-
-
Zitvogel, L.1
Apetoh, L.2
Ghiringhelli, F.3
André, F.4
Tesniere, A.5
Kroemer, G.6
-
4
-
-
70350500225
-
STATs in cancer inflammation and immunity: a leading role for STAT3
-
Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 2009; 9:798-809; http://dx. doi.org/10.1038/nrc2734
-
(2009)
Nat Rev Cancer
, vol.9
, pp. 798-809
-
-
Yu, H.1
Pardoll, D.2
Jove, R.3
-
5
-
-
78650859531
-
-κB and STAT3 - key players in liver inflammation and cancer
-
He G, Karin MNF. -κB and STAT3 - key players in liver inflammation and cancer. Cell Res 2011; 21:159-68; http://dx.doi.org/10.1038/cr. 2010.183
-
(2011)
Cell Res
, vol.21
, pp. 159-168
-
-
He, G.1
Karin, M.N.F.2
-
6
-
-
79955776494
-
In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression
-
Park O, Wang H, Weng H, Feigenbaum L, Li H, Yin S, et al. In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression. Hepatology 2011; 54:252-61; http://dx.doi.org/10.1002/hep.24339
-
(2011)
Hepatology
, vol.54
, pp. 252-261
-
-
Park, O.1
Wang, H.2
Weng, H.3
Feigenbaum, L.4
Li, H.5
Yin, S.6
-
7
-
-
0028012009
-
Chronic active hepatitis in transgenic mice expressing Interferon-γ in the liver
-
Toyonaga T, Hino O, Sugai S, Wakasugi S, Abe K, Shichiri M, et al. Chronic active hepatitis in transgenic mice expressing Interferon-γ in the liver. Proc Natl Acad Sci USA 1994; 91:614-8; http://dx.doi.org/10.1073/pnas.91.2.614
-
(1994)
Proc Natl Acad Sci USA
, vol.91
, pp. 614-618
-
-
Toyonaga, T.1
Hino, O.2
Sugai, S.3
Wakasugi, S.4
Abe, K.5
Shichiri, M.6
-
8
-
-
79957922293
-
Chronic inflammatory IFN-c signaling suppresses hepatocarcinogenesis in mice by sensitizing hepatocytes for apoptosis
-
Lüth S, Schrader J, Zander S, Carambia A, Buchkremer J, Huber S, et al. Chronic inflammatory IFN-c signaling suppresses hepatocarcinogenesis in mice by sensitizing hepatocytes for apoptosis. Cancer Res 2011; 71:3763-71; http://dx.doi.org/10.1158/0008-5472.CAN-10-3232
-
(2011)
Cancer Res
, vol.71
, pp. 3763-3771
-
-
Lüth, S.1
Schrader, J.2
Zander, S.3
Carambia, A.4
Buchkremer, J.5
Huber, S.6
-
9
-
-
33947423447
-
Modulation of signal transducers and activators of transcription 1 and 3 signaling in melanoma by high-dose IFNalpha2b
-
Wang W, Edington HD, Rao UN, Jukic DM, Land SR, Ferrone S, et al. Modulation of signal transducers and activators of transcription 1 and 3 signaling in melanoma by high-dose IFNalpha2b. Clin Cancer Res 2007; 13:1523-31; http://dx.doi. org/10.1158/1078-0432.CCR-06-1387
-
(2007)
Clin Cancer Res
, vol.13
, pp. 1523-1531
-
-
Wang, W.1
Edington, H.D.2
Rao, U.N.3
Jukic, D.M.4
Land, S.R.5
Ferrone, S.6
|